Experimental drug doubles one-year survival in pancreatic cancer
A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
1 Comment so far
Thank you for providing such a balanced and complete overview. It is quite encouraging to encounter content that remains perfectly unbiased while still delivering all the essential details in a logical sequence that keeps the reader fully engaged from start to finish.
Thank you for providing such a balanced and complete overview. It is quite encouraging to encounter content that remains perfectly unbiased while still delivering all the essential details in a logical sequence that keeps the reader fully engaged from start to finish.
https://digitalhealthfundingnews.com